Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

• Status: Completed
• Trial end date: 2018-12-06
• Target enrollment: 0
• Participant gender: Female

Summary

Bemiparin for pregnant women with abnormal umbilical artery Doppler ultrasound

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hawler Medical University
• Treatments: Bemiparin; Calcium heparin; Dalteparin; Heparin; Heparin, Low-Molecular-Weight

Criteria

Inclusion Criteria:

• Second pregnancy after previous unexplained fetal death

• Singleton pregnancy

• No any medical disorders during pregnancy like diabetes or Systemic Lupus Erythematosus

• Normally located placenta

• No congenital fetal anomalies

• Patient accept to participate

Exclusion Criteria:

• Confirmed thrombophilia

• Twin pregnancies

• Refused to participate